IPSCNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Century Therapeutics, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 12, 2026
$1.47+0.10 (+7.30%)
Close on Oct 19, 2026
- Market cap
- $302.49M
- P/E (TTM)
- –
- Dividend yield
- –
SEC filings
40 of Century Therapeutics's most recent filings on SEC EDGAR
| Document | Form | Period | Filed | Source |
|---|---|---|---|---|
| Current report | 8-K | Oct 2, 2026 | Oct 2, 2026 | SEC EDGAR |
| Current report | 8-K | Sep 9, 2026 | Sep 9, 2026 | SEC EDGAR |
| Current report | 8-K | Aug 12, 2026 | Aug 12, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2026 | Aug 12, 2026 | SEC EDGAR |
| Current report | 8-K | Jun 15, 2026 | Jun 16, 2026 | SEC EDGAR |
| Current report | 8-K | Jun 11, 2026 | Jun 12, 2026 | SEC EDGAR |
| Current report | 8-K | Jun 8, 2026 | Jun 8, 2026 | SEC EDGAR |
| Current report | 8-K | May 13, 2026 | May 13, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2026 | May 13, 2026 | SEC EDGAR |
| Proxy statement | DEF 14A | Jun 11, 2026 | Apr 27, 2026 | SEC EDGAR |
| Current report | 8-K | Mar 26, 2026 | Mar 26, 2026 | SEC EDGAR |
| Current report | 8-K | Mar 12, 2026 | Mar 12, 2026 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2025 | Mar 12, 2026 | SEC EDGAR |
| Current report | 8-K | Jan 22, 2026 | Jan 23, 2026 | SEC EDGAR |
| Current report | 8-K | Jan 12, 2026 | Jan 12, 2026 | SEC EDGAR |
| Current report | 8-K | Jan 7, 2026 | Jan 8, 2026 | SEC EDGAR |
| Current report | 8-K | Dec 18, 2025 | Dec 29, 2025 | SEC EDGAR |
| Current report | 8-K | Dec 12, 2025 | Dec 12, 2025 | SEC EDGAR |
| Current report | 8-K | Dec 9, 2025 | Dec 9, 2025 | SEC EDGAR |
| Proxy statement | DEF 14A | Jan 22, 2026 | Dec 2, 2025 | SEC EDGAR |
| Current report | 8-K | Nov 13, 2025 | Nov 13, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2025 | Nov 13, 2025 | SEC EDGAR |
| Current report | 8-K | Aug 27, 2025 | Aug 29, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2025 | Aug 14, 2025 | SEC EDGAR |
| Current report | 8-K | Aug 13, 2025 | Aug 14, 2025 | SEC EDGAR |
| Current report | 8-K | Jul 1, 2025 | Jul 7, 2025 | SEC EDGAR |
| Current report | 8-K | Jun 12, 2025 | Jun 16, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2025 | May 15, 2025 | SEC EDGAR |
| Current report | 8-K | May 15, 2025 | May 15, 2025 | SEC EDGAR |
| Proxy statement | DEF 14A | Jun 12, 2025 | Apr 22, 2025 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2024 | Mar 19, 2025 | SEC EDGAR |
| Current report | 8-K | Mar 19, 2025 | Mar 19, 2025 | SEC EDGAR |
| Current report | 8-K | Feb 26, 2025 | Feb 28, 2025 | SEC EDGAR |
| Current report | 8-K | Jan 13, 2025 | Jan 13, 2025 | SEC EDGAR |
| Current report | 8-K | Dec 12, 2024 | Dec 13, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2024 | Nov 5, 2024 | SEC EDGAR |
| Current report | 8-K | Nov 5, 2024 | Nov 5, 2024 | SEC EDGAR |
| Current report | 8-K | Sep 26, 2024 | Sep 26, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2024 | Aug 8, 2024 | SEC EDGAR |
| Current report | 8-K | Aug 8, 2024 | Aug 8, 2024 | SEC EDGAR |